代谢联盟：肥胖症的药物治疗和运动管理。

IF 31 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

Nature Reviews Endocrinology Pub Date : 2024-06-05 DOI:10.1038/s41574-024-01006-7

Javier Butragueño, Jonatan R. Ruiz

引用次数: 0

摘要

基于胰岛素激素的抗肥胖药物可促进肥胖症患者的体重控制和新陈代谢健康。运动是提高治疗效果的重要代谢盟友，它可以促进肥胖症治疗的长期成功。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Metabolic alliance: pharmacotherapy and exercise management of obesity

查看原文本刊更多论文

Metabolic alliance: pharmacotherapy and exercise management of obesity

Anti-obesity medications based on incretin hormones have advanced weight control and metabolic health in individuals with obesity. The long-term success of obesity therapeutics could be facilitated by exercise, a vital metabolic ally in enhancing treatment efficacy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Endocrinology 医学-内分泌学与代谢

CiteScore

42.00

自引率

0.70%

发文量

158

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Endocrinology aspires to be the foremost platform for reviews and commentaries catering to the scientific communities it serves. The journal aims to publish articles characterized by authority, accessibility, and clarity, enhanced with easily understandable figures, tables, and other visual aids. The goal is to offer an unparalleled service to authors, referees, and readers, striving to maximize the usefulness and impact of each article. Nature Reviews Endocrinology publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians in the fields of endocrinology and metabolism. Its broad scope ensures that the work it publishes reaches the widest possible audience.